Lupin announced that it has received the highest ‘A’ leadership rating from the Climate Disclosure Project (CDP) for its accomplishments in Climate Change and Water Security. This acknowledges Lupin’s position as a global leader in sustainability. The company’s double ‘A’ rating exemplifies its commitment to reducing climate risks and responsible water management. Lupin also achieved an S&P Global ESG score of 91 in 2025.
Top Tier Recognition
Global pharmaceutical company Lupin has been awarded the highest ‘A’ rating from the Climate Disclosure Project (CDP) for its leadership in both Climate Change and Water Security. The announcement, dated January 23, 2026, recognizes the company’s commitment to sustainability and transparency.
Commitment to Sustainability
Lupin’s double ‘A’ rating reflects its dedication to mitigating climate risks, lowering carbon emissions, and ensuring responsible water management in its operations. The 2025 double ‘A’ rating is an improvement from the company’s 2024 ratings of ‘A-’ in both categories, and ‘B’ for climate and ‘C’ for water in 2023.
Executive Commentary
Ramesh Swaminathan, Executive Director, Global CFO and Head – API Plus SBU, Lupin, stated, “As a global pharma leader, we have significantly advanced our efforts to reduce environmental impact through innovation, collaboration, and transparency. We are proud to have earned CDP’s Double ‘A’ rating… We are committed to establishing new sustainability standards and generating lasting value for our communities and the planet.”
S&P Global ESG Score
In addition to the CDP recognition, Lupin achieved an S&P Global ESG score of 91 in 2025, surpassing the 90-point threshold and placing it among top-rated companies worldwide.
Source: BSE
